rs56180838

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_000719.7(CACNA1C):​c.4038C>T​(p.Ile1346Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.058 in 1,613,286 control chromosomes in the GnomAD database, including 3,153 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.045 ( 205 hom., cov: 31)
Exomes 𝑓: 0.059 ( 2948 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.16

Publications

13 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.25).
BP6
Variant 12-2651732-C-T is Benign according to our data. Variant chr12-2651732-C-T is described in ClinVar as Benign. ClinVar VariationId is 136623.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.16 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0644 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000719.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
NM_000719.7
MANE Select
c.4038C>Tp.Ile1346Ile
synonymous
Exon 32 of 47NP_000710.5
CACNA1C
NM_001167623.2
MANE Plus Clinical
c.4038C>Tp.Ile1346Ile
synonymous
Exon 32 of 47NP_001161095.1
CACNA1C
NM_199460.4
c.4182C>Tp.Ile1394Ile
synonymous
Exon 34 of 50NP_955630.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
ENST00000399603.6
TSL:5 MANE Plus Clinical
c.4038C>Tp.Ile1346Ile
synonymous
Exon 32 of 47ENSP00000382512.1
CACNA1C
ENST00000399655.6
TSL:1 MANE Select
c.4038C>Tp.Ile1346Ile
synonymous
Exon 32 of 47ENSP00000382563.1
CACNA1C
ENST00000682544.1
c.4272C>Tp.Ile1424Ile
synonymous
Exon 34 of 50ENSP00000507184.1

Frequencies

GnomAD3 genomes
AF:
0.0447
AC:
6792
AN:
152058
Hom.:
205
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0111
Gnomad AMI
AF:
0.0417
Gnomad AMR
AF:
0.0378
Gnomad ASJ
AF:
0.0545
Gnomad EAS
AF:
0.000580
Gnomad SAS
AF:
0.0152
Gnomad FIN
AF:
0.0807
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0660
Gnomad OTH
AF:
0.0484
GnomAD2 exomes
AF:
0.0477
AC:
11844
AN:
248480
AF XY:
0.0486
show subpopulations
Gnomad AFR exome
AF:
0.0112
Gnomad AMR exome
AF:
0.0277
Gnomad ASJ exome
AF:
0.0505
Gnomad EAS exome
AF:
0.000222
Gnomad FIN exome
AF:
0.0826
Gnomad NFE exome
AF:
0.0672
Gnomad OTH exome
AF:
0.0542
GnomAD4 exome
AF:
0.0594
AC:
86756
AN:
1461110
Hom.:
2948
Cov.:
33
AF XY:
0.0583
AC XY:
42369
AN XY:
726786
show subpopulations
African (AFR)
AF:
0.00854
AC:
286
AN:
33474
American (AMR)
AF:
0.0298
AC:
1331
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.0510
AC:
1332
AN:
26104
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39696
South Asian (SAS)
AF:
0.0186
AC:
1603
AN:
86216
European-Finnish (FIN)
AF:
0.0859
AC:
4582
AN:
53346
Middle Eastern (MID)
AF:
0.0265
AC:
153
AN:
5764
European-Non Finnish (NFE)
AF:
0.0668
AC:
74241
AN:
1111472
Other (OTH)
AF:
0.0534
AC:
3220
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
4220
8440
12660
16880
21100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2678
5356
8034
10712
13390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0446
AC:
6792
AN:
152176
Hom.:
205
Cov.:
31
AF XY:
0.0445
AC XY:
3314
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.0111
AC:
460
AN:
41536
American (AMR)
AF:
0.0377
AC:
577
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0545
AC:
189
AN:
3470
East Asian (EAS)
AF:
0.000581
AC:
3
AN:
5160
South Asian (SAS)
AF:
0.0154
AC:
74
AN:
4806
European-Finnish (FIN)
AF:
0.0807
AC:
856
AN:
10606
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0660
AC:
4485
AN:
67988
Other (OTH)
AF:
0.0479
AC:
101
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
332
664
996
1328
1660
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0545
Hom.:
187
Bravo
AF:
0.0394
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.0644
EpiControl
AF:
0.0662

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Long QT syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.25
CADD
Benign
13
DANN
Benign
0.85
PhyloP100
3.2
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56180838; hg19: chr12-2760898; COSMIC: COSV59779215; API